Cargando…
Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab
The current pandemic emergence of novel coronavirus disease (COVID-19) poses a relevant threat to global health. SARS-CoV-2 infection is characterized by a wide range of clinical manifestations, ranging from absence of symptoms to severe forms that need intensive care treatment. Here, plasma-EDTA sa...
Autores principales: | Meoni, Gaia, Ghini, Veronica, Maggi, Laura, Vignoli, Alessia, Mazzoni, Alessio, Salvati, Lorenzo, Capone, Manuela, Vanni, Anna, Tenori, Leonardo, Fontanari, Paolo, Lavorini, Federico, Peris, Adriano, Bartoloni, Alessandro, Liotta, Francesco, Cosmi, Lorenzo, Luchinat, Claudio, Annunziato, Francesco, Turano, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877736/ https://www.ncbi.nlm.nih.gov/pubmed/33524041 http://dx.doi.org/10.1371/journal.ppat.1009243 |
Ejemplares similares
-
Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab
por: Salvati, Lorenzo, et al.
Publicado: (2020) -
High‐Throughput Metabolomics by 1D NMR
por: Vignoli, Alessia, et al.
Publicado: (2018) -
Serum NMR Profiling Reveals Differential Alterations in the Lipoproteome Induced by Pfizer-BioNTech Vaccine in COVID-19 Recovered Subjects and Naïve Subjects
por: Ghini, Veronica, et al.
Publicado: (2022) -
Therapeutical Targets in Allergic Inflammation
por: Salvati, Lorenzo, et al.
Publicado: (2022) -
Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion
por: Mazzoni, Alessio, et al.
Publicado: (2021)